Regulatory issues in the evaluation of antimetastatic and other novel anticancer therapies

Cancer Chemotherapy and Pharmacology, Supplement

Volumn 43, Issue , 1999, Pages

  Friedman, M A ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Antimetastatic drugs; Clinical trials; Regulation; US Food and Drug Administration

Indexed keywords

CANCER RESEARCH; CONFERENCE PAPER; DRUG MONITORING; DRUG RESEARCH; FOOD AND DRUG ADMINISTRATION; METASTASIS INHIBITION; PRIORITY JOURNAL;

EID: 0033055609     PISSN: 09439404     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800051106     Document Type: Conference Paper

References (0)